Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep (Q39198268)

9 September 2017

title

Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep (English)

1 reference

Rift Valley fever phlebovirus

9 September 2017

main subject

0 references

Rift Valley fever

1 reference

based on heuristic

inferred from title

Rift Valley fever virus

object named as

Rift Valley fever virus

1 reference

8

Clarence J Peters

1 reference

9 September 2017

Hana M Weingartl

1

1 reference

9 September 2017

Charles K Nfon

2

1 reference

9 September 2017

Shunzhen Zhang

3

1 reference

9 September 2017

Peter Marszal

4

1 reference

9 September 2017

William C Wilson

5

1 reference

9 September 2017

John C Morrill

6

1 reference

9 September 2017

George E Bettinger

7

1 reference

9 September 2017

language of work or name

English

0 references

publication date

24 January 2014

1 reference

9 September 2017

1 reference

9 September 2017

volume

32

1 reference

9 September 2017

issue

20

1 reference

9 September 2017

page(s)

2345-2349

1 reference

Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

7 January 2021

Rift Valley fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Novel approaches to develop Rift Valley fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Innate immune response to Rift Valley fever virus in goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.064

10.1016/J.VACCINE.2013.12.064

7 January 2021

Identifiers

DOI

1 reference

release_x6rvdxhghrgrblr5cgevbrpuzq

9 September 2017

Fatcat ID

0 references

1 reference